Annual screen for younger at-risk women picks up more early stage breast cancers, research shows
If checks for women with family history were extended to 35-39 year olds, some 86,000 women in the UK could benefit, say the researchers Related items fromOnMedica Cancer research in the era of immunogenomics Social media could help raise breast screening take-up Breast cancer screening linked to substantial lower risk of death Screening programmes in England fail to meet standard uptake targets Cervical screening intervals should be extended (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 11, 2019 Category: UK Health Source Type: news

Codilia designs false lashes for cancer patients.
After Codilia was diagnosed with breast cancer, there was one problem she decided to try to fix herself. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - February 10, 2019 Category: Consumer Health News Source Type: news

Breast cancer doesn't mean the end of your sex life
Talking about sex is difficult at the best of times – and particularly when things aren’t going right. Most of us will be reluctant to bring it up with our partner, let alone a doctor, writes LIZ O'RIORDAN. (Source: the Mail online | Health)
Source: the Mail online | Health - February 9, 2019 Category: Consumer Health News Source Type: news

HeartFlow publishes findings from consumer survey
HeartFlow this week published the findings of a 1,500-person consumer survey, reporting that just 29% of respondents knew that heart disease is the No. 1 cause of death among adults in the U.S. Half of the survey’s participants said that breast cancer is the leading cause of death among women, rather than heart disease. “We are aiming to raise awareness that heart disease is the leading cause of death for both women and men. It’s not just a man’s disease, as commonly thought,” Dr. Campbell Rogers, HeartFlow’s chief medical officer, said in prepared remarks. “The symptoms for women ...
Source: Mass Device - February 8, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Featured Research & Development HeartFlow Source Type: news

Chef Sandra Lee Strives to Make Cancer Screenings Accessible
Courtesy HBO ... One in 8 American women will develop breast cancer at some point in their lives. ... The median age of diagnosis is 62. ... And for most women over 50, the lifesaving benefits of a... (Source: AARP.org News)
Source: AARP.org News - February 8, 2019 Category: American Health Source Type: news

The Union for International Cancer Control and Pfizer announce new phase of global grants initiative supporting metastatic breast cancer patients
In conjunction with World Cancer Day, the Union for International Cancer Control (UICC) and Pfizer Inc. announce the third round of the Seeding Progress And Resources for the Cancer Community (SPARC): Metastatic Breast Cancer (MBC) Challenge: their pioneering grants initiative designed to (Source: World Pharma News)
Source: World Pharma News - February 8, 2019 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

AI may predict lymph node metastasis in gastric cancer
The combination of artificial intelligence (AI) and radiomics features on CT...Read more on AuntMinnie.comRelated Reading: AI can predict breast cancer molecular subtypes on MRI Russian AI detects lung cancer on CT in 20 seconds AI can differentiate glioblastoma, brain metastasis AI uses features outside nodules to predict malignancy Surgery plus RT works best for metastatic gastric cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 8, 2019 Category: Radiology Source Type: news

AI singles out high-risk prostate cancer on mpMRI
Working with radiomics data on multiparametric MRI (mpMRI) scans, an artificial...Read more on AuntMinnie.comRelated Reading: Advanced imaging offers insight into targeted therapies AI can predict breast cancer molecular subtypes on MRI AI can differentiate glioblastoma, brain metastasis CT radiomics improves management of bile duct cancer Faster MRI protocol avoids unneeded prostate biopsies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 8, 2019 Category: Radiology Source Type: news

Higher dose of chemotherapy reduces breast cancer recurrence
Giving chemotherapy drugs every two weeks instead of the usual every three weeks reduces the risk of breast cancer recurrence and death, according to new research. (Source: Medical Research Council General News)
Source: Medical Research Council General News - February 8, 2019 Category: Research Source Type: news

Robotic Mastectomy in US: Starts, Draws Fire, Stops Robotic Mastectomy in US: Starts, Draws Fire, Stops
The first-ever robotic mastectomy for invasive breast cancer in the US took place last year, but the New Jersey center later stopped performing the procedure. Experts are now debating what the future holds.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 7, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

FDA Warns Doctors to Look Out for Rare Cancer Linked to Breast Implants
(WASHINGTON) — U.S. health officials say doctors should be on the lookout for a rare cancer linked to breast implants after receiving more reports of the disease. The Food and Drug Administration sent a letter late Wednesday to family doctors, nurses and other health professionals warning about the form of lymphoma in breast implant patients. In suspected cases, the FDA recommends laboratory testing to confirm or rule out of the disease. It’s the first time regulators have issued such a warning to doctors other than plastic surgeons. The disease is not breast cancer, but usually forms in the scar tissue that fo...
Source: TIME: Health - February 7, 2019 Category: Consumer Health News Authors: MATTHEW PERRONE / AP Tags: Uncategorized Cancer onetime Source Type: news

Breast implants linked to lymphoma, FDA says
Breast implants are causing more deadly breast cancer among women, according to the U.S. Food and Drug Administration. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 7, 2019 Category: Consumer Health News Source Type: news

Chef Sandra Lee Rose to Fame on Charm and Cool Whip. Now She ’s Taking on Cancer
Sandra Lee, the creator of the Semi-Homemade brand of cookbooks, magazines and TV shows and a person who leaves nothing to chance, is sitting in a high-ceilinged ballroom on Wall Street on a rainy evening the weekend after Thanksgiving, listening to a local official present her with a tribute. But, sincere as the speech is, it cannot be heard over the chatter of the members of the New York City independent-film community who have turned out for the IFP Gotham awards. This is not Lee’s usual audience. To New York’s indie-film elite, she is that woman who rose to fame on her ability to gussy up ready-made food in...
Source: TIME: Health - February 7, 2019 Category: Consumer Health News Authors: Belinda Luscombe Tags: Uncategorized celebrity Source Type: news

Primary doctors can help boost mammography compliance
When primary care physicians are in regular contact with their patients, women...Read more on AuntMinnie.comRelated Reading: Racial factors affect time to breast cancer treatment Black women have worse breast cancer outcomes Patient navigators help black women with mammograms Race matters for breast cancer screening protocols Breast cancer screening gaps exist for minority women (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 7, 2019 Category: Radiology Source Type: news

Nigeria: High Cost of Few Cancer Screening, Treatment Centres Reduces Patients' Survival Chances
[Guardian] Mrs Nwabufo Chika, (fondly nicknamed 'Ika') has been a breast cancer survivor for six years. Unfortunately, last year November, the cancer spread to her spine... . and affected her walking. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 7, 2019 Category: African Health Source Type: news

Is DFS an Appropriate Surrogate for OS in Early HER2+ Breast Cancer?
The study findings suggest that disease-free survival can continue to be used as a surrogate endpoint in the setting of early HER2+ breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - February 7, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Breast cancer cells shifted into HER2 positive status with bold new strategy
(Scripps Research Institute) One of the most effective breast cancer drugs, Herceptin, is only available to people whose tumors test HER2-positive. That's only one in five breast cancer patients. That could change with a new approach from Scripps Research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 7, 2019 Category: Cancer & Oncology Source Type: news

MacroGenics stock spikes from positive results of cancer drug trial
Rockville-based MacroGenics Inc. announced positive results Wednesday from late-stage trials of its breast cancer therapy candidate, sending the company ’s stock price soaring nearly 200 percent for the day. The biotech’s margetuximab product — which targets the “HER2” gene, which can feed the growth of cancer cells, specifically in patients with metastatic breast cancer — was found to be safer and better tolerated than Genentech Inc.'s Herceptin, considered a standard treatment today,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 6, 2019 Category: Biotechnology Authors: Sara Gilgore Source Type: news

MacroGenics stock spikes from positive results of cancer drug trial
Rockville-based MacroGenics Inc. announced positive results Wednesday from late-stage trials of its breast cancer therapy candidate, sending the company ’s stock price soaring nearly 200 percent for the day. The biotech’s margetuximab product — which targets the “HER2” gene, which can feed the growth of cancer cells, specifically in patients with metastatic breast cancer — was found to be safer and better tolerated than Genentech Inc.'s Herceptin, considered a standard treatment today,… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - February 6, 2019 Category: Health Management Authors: Sara Gilgore Source Type: news

Beneficial bacteria in the breasts can protect women from cancer
(Natural News) Probiotics promote digestive health. But according to a study, probiotics can also help lower your risk of developing breast cancer. The study results were published in the journal Applied and Environmental Microbiology in collaboration with the American Society for Microbiology. Probiotics and breast cancer prevention Probiotics are associated with an improved digestive and... (Source: NaturalNews.com)
Source: NaturalNews.com - February 6, 2019 Category: Consumer Health News Source Type: news

Thrombosis a Risk With Tamoxifen in Male Breast Cancer
(MedPage Today) -- Data consistent with findings in women (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 6, 2019 Category: Cardiology Source Type: news

Combo of diabetes, leukemia drugs may fight breast cancer
A combination of popular diabetes and immunotherapy drugs can kill breast cancer, a new study says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 6, 2019 Category: Consumer Health News Source Type: news

AI can predict breast cancer molecular subtypes on MRI
Can an artificial intelligence (AI) algorithm identify the molecular subtype...Read more on AuntMinnie.comRelated Reading: Russian AI detects lung cancer on CT in 20 seconds AI can detect, localize fractures on wrist x-rays AI reveals cause of transient ischemic attack symptoms Breast MRI effective as adjunct to DBT in high-risk women AI uses features outside nodules to predict malignancy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 6, 2019 Category: Radiology Source Type: news

Carbon-11 PET detects brain inflammation after Lyme disease
Researchers at Johns Hopkins Medicine have developed a PET imaging technique...Read more on AuntMinnie.comRelated Reading: PET's view of tau could explain women's early dementia PET in the paddock New PET tracer could aid melanoma detection PET tracers help guide breast cancer therapies C-11-based PET tracer could benefit arthritis patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 6, 2019 Category: Radiology Source Type: news

Combination treatment, diabetes drug and immunotherapy, may help to fight breast cancer
(University of Helsinki) Researchers in Finland have discovered a drug combination that collaborates with the cancer cells' own MYC oncoprotein, which in large quantities causes self-destruction of the cancer cells. When this combination is enhanced with immune system-boosting anti-PD-1 therapy, a more effective and long-lasting therapeutic effect can be seen in mice. These findings pave the way for new treatment combination strategies to harness the body's natural defenses to fight cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 6, 2019 Category: Cancer & Oncology Source Type: news

Study examines race-based differences in social support needs among breast cancer patients
(Wiley) In a Psycho-Oncology study of 28 women who were being treated for breast cancer and were participating in focus groups, White participants noted that having other breast cancer survivors in their support network was essential for meeting their social support needs. Black participants did not reference other breast cancer survivors as part of their networks, however. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2019 Category: International Medicine & Public Health Source Type: news

UCLA ’s Dennis Slamon awarded Sjöberg Prize for pioneering cancer research
Dr. Dennis Slamon, director of the Revlon/UCLA Women ’s Cancer Research Program, has been named a co-winner of the 2019 Sjöberg Prize by the Royal Swedish Academy of Sciences and Sweden’s Sjöberg Foundation. Honored for his groundbreaking research that led to the development of successful targeted cancer therapies, Slamon shares the award with D r. Brian Druker of Oregon Health& Science University.The Sj öberg Prize has been awarded annually since 2016 to recognize outstanding cancer research. The honor carries a prize of $1 million — $100,000 as award money and $900,000 to fund future ...
Source: UCLA Newsroom: Health Sciences - February 5, 2019 Category: Universities & Medical Training Source Type: news

Roche wins speedy FDA review to adapt breast cancer med
The FDA will be reviewing Kadcyla under its Real-Time Oncology Review and Assessment Aid pilot program (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - February 5, 2019 Category: Pharmaceuticals Source Type: news

Roche adapts newer breast cancer drug in face of Herceptin imitations
Swiss drugmaker Roche aims to broaden the use of its Kadcyla breast cancer treatment as rivals crowd into the market with biosimilar copies of its older mainstay Herceptin. (Source: Reuters: Health)
Source: Reuters: Health - February 5, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Nigeria: Polaris Bank Commemorates World Cancer Day
[Vanguard] In commemoration of the 2019 World Cancer Day and demonstration of its unwavering commitment to the fight against breast cancer in Nigeria, Polaris Bank has encouraged Nigerians to pay more attention to their eating habit and lifestyle in general to avoid contracting cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 5, 2019 Category: African Health Source Type: news

Roche moves to broaden Kadcyla use in biosimilar defense
Roche aims to broaden use of its Kadcyla breast cancer drug as the Swiss pharmaceuticals giant defends itself against rivals who are crowding in with cheaper biosimilar copies of its older, patent-expired mainstay Herceptin. (Source: Reuters: Health)
Source: Reuters: Health - February 5, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Roche submits supplemental biologics license application to the US FDA for Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment
Roche today announced completing the submission of a supplemental Biologics License Application to the US Food and Drug Administration (FDA) for Kadcyla ® (trastuzumab emtansine) for adjuvant (after surgery) treatment of people with HER2-positive early breast cancer (eBC) with residual disease after neoadjuvant (before surgery) treatment. (Source: Roche Investor Update)
Source: Roche Investor Update - February 5, 2019 Category: Pharmaceuticals Source Type: news

Roche submits supplemental biologics license application to the US FDA for Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment
Roche today announced completing the submission of a supplemental Biologics License Application to the US Food and Drug Administration (FDA) for Kadcyla ® (trastuzumab emtansine) for adjuvant (after surgery) treatment of people with HER2-positive early breast cancer (eBC) with residual disease after neoadjuvant (before surgery) treatment. (Source: Roche Media News)
Source: Roche Media News - February 5, 2019 Category: Pharmaceuticals Source Type: news

Low muscle mass in women diagnosed with breast cancer linked to worse survival
(Natural News) Of the different types of cancer, breast cancer is among those with higher chances of survival, especially with early detection and diagnosis. However, one study discovered additional factors that may increase the risk of death for women suffering from this condition. Sarcopenia, a condition wherein a person has low skeletal muscle mass, was found... (Source: NaturalNews.com)
Source: NaturalNews.com - February 5, 2019 Category: Consumer Health News Source Type: news

Pfizer's Trastuzumab Biosimilar Noninferior in Two Breast Ca Trials
(MedPage Today) -- Results similar to branded drug in metastatic, neoadjuvant breast cancer studies (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - February 4, 2019 Category: OBGYN Source Type: news

Nigeria: World Cancer Day - Ondo Governor's Wife Calls for Concerted Effort to Fight Scourge
[Vanguard] The Wife of Ondo State Governor and Founder of Breast Cancer Association of Nigeria, (BRECAN) Mrs Betty Akeredolu, has called for concerted efforts to fight the scourge of cancer in the country. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 4, 2019 Category: African Health Source Type: news

Drug target identified for chemotherapy-resistant ovarian, breast cancer
People who inherit a faulty copy of the so-called "breast cancer genes" BRCA1 and BRCA2 are at high risk of cancer. About 10 percent of breast cancer cases and 15 percent of ovarian cancers can be traced back to a flaw in one of these genes. A class of drugs known as PARP inhibitors was designed to target tumors with defective BRCA genes. (Source: World Pharma News)
Source: World Pharma News - February 4, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Radiotherapy in Early-Stage Hormone-Sensitive Breast Cancer Radiotherapy in Early-Stage Hormone-Sensitive Breast Cancer
Does omission of radiotherapy affect recurrence and mortality in early stage hormone-sensitive breast cancer?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 4, 2019 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Identification of HER2 IHC-Negative, FISH+ Breast Cancers Identification of HER2 IHC-Negative, FISH+ Breast Cancers
Both immunohistochemistry for protein expression or fluorescent in situ hybridization for gene amplification can be used to determine HER2 status in breast cancer--but what if they don't agree?American Journal of Clinical Pathology (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 4, 2019 Category: Pathology Tags: Pathology & Lab Medicine Journal Article Source Type: news

Drug target identified for chemotherapy-resistant ovarian, breast cancer
(Washington University School of Medicine) Researchers at Washington University School of Medicine in St. Louis may have found a path toward improving the effectiveness of chemotherapy in people with breast or ovarian cancer caused by defects in one of the BRCA genes. The researchers identified a pair of genes that operate in parallel to BRCA and may increase susceptibility to chemotherapy drugs. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 4, 2019 Category: Cancer & Oncology Source Type: news

Shared genetic marker offers new promise in targeting specific ovarian and lung cancers
(McGill University) Two new papers, published simultaneously in Nature Communications and led by researchers at McGill University, offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer, one rare and one common form. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 4, 2019 Category: Cancer & Oncology Source Type: news

Revealing the path of a metallodrug in a breast cancer cell
This study is published in Angewandte Chemie. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 4, 2019 Category: Biology Source Type: news

Gladys Knight: Singer's secret battle with breast cancer - how to spot the symptoms
GLADYS KNIGHT is set to sing the national anthem at Super Bowl LIII. The seven-time Grammy Award winner will be representing her home city of Atlanta - the city hosting the event. But amidst her many successful years in the music industry, Gladys has also endured a secret battle with cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - February 3, 2019 Category: Consumer Health News Source Type: news

Use of Image Analysis to ID HER2 Status in Breast Cancer Outlined
FRIDAY, Feb. 1, 2019 -- Recommendations have been developed to improve accuracy, precision, and reproducibility in the interpretation of human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) results for breast cancer with use of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 1, 2019 Category: Pharmaceuticals Source Type: news

Finally, Metastatic Breast Cancer Patients Get VIP Treatment Finally, Metastatic Breast Cancer Patients Get VIP Treatment
A first-of-its-kind US clinic aims to change the care model for metastatic breast cancer patients, a subgroup that has been historically underserved.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 1, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Transforming cities: the potential of everyday cycling
This report estimates that 34,000 incidences of eight conditions, including type 2 diabetes, stroke, breast cancer and depression, would be prevented in seven major cities between 2017 and 2040, if cycling increased at rates like those seen since the millennium in London. The report outlines actions for local government to help increase and normalise cycling for local journeys (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 1, 2019 Category: Consumer Health News Source Type: news

' Dense' Breast Rates Steady With Changing Guidelines and Technology'Dense' Breast Rates Steady With Changing Guidelines and Technology
The percentage of digital mammography screens assessed as dense has remained steady with changes in Breast Imaging Reporting and Data System (BI-RADS) guidelines and implementation of digital breast tomosynthesis, according to findings from the Breast Cancer Surveillance Consortium (BCSC).Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 1, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Hypofractionated Radiotherapy Offers an Alternative in High-Risk Breast Cancer
Researchers compared hypofractionated radiotherapy vs a conventional regimen to study outcomes and toxicity in breast cancer patients. (Source: CancerNetwork)
Source: CancerNetwork - February 1, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news